Eco R1 Capital, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $3.51 Billion
- Q1 2024
A detailed history of Eco R1 Capital, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 4,155,375 shares of CRNX stock, worth $186 Million. This represents 5.55% of its overall portfolio holdings.
Number of Shares
4,155,375
Previous 2,012,517
106.48%
Holding current value
$186 Million
Previous $71.6 Million
171.65%
% of portfolio
5.55%
Previous 2.06%
Shares
9 transactions
Others Institutions Holding CRNX
# of Institutions
220Shares Held
75.8MCall Options Held
631KPut Options Held
749K-
Black Rock Inc. New York, NY5.44MShares$244 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.23MShares$235 Million2.68% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.95MShares$222 Million0.59% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$172 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$160 Million0.0% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.41B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...